Assay ID | Title | Year | Journal | Article |
AID84399 | Inhibition against DNA-Dependent ATPase activity of HSV-1 helicase-primase in HSV-1-infected CV-1 cells | 1995 | Journal of medicinal chemistry, May-12, Volume: 38, Issue:10
| Inhibition of herpes simplex virus type 1 helicase-primase by (dichloroanilino)purines and -pyrimidines. |
AID210696 | Inhibition of HSV-1 thymidine kinase, 1 uM [3H]thymidine and ATP as phosphate donor | 1995 | Journal of medicinal chemistry, Jan-06, Volume: 38, Issue:1
| Synthesis, properties, and pharmacokinetic studies of N2-phenylguanine derivatives as inhibitors of herpes simplex virus thymidine kinases. |
AID210714 | Inhibitory activity against HSV-2 thymidine kinase isolated from HeLa cells | 1992 | Journal of medicinal chemistry, Aug-07, Volume: 35, Issue:16
| Quantitative structure-activity relationships of N2-phenylguanines as inhibitors of herpes simplex virus thymidine kinases. |
AID14665 | Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle | 1995 | Journal of medicinal chemistry, Jan-06, Volume: 38, Issue:1
| Synthesis, properties, and pharmacokinetic studies of N2-phenylguanine derivatives as inhibitors of herpes simplex virus thymidine kinases. |
AID25177 | Half life in mice plasma was determined at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle | 1995 | Journal of medicinal chemistry, Jan-06, Volume: 38, Issue:1
| Synthesis, properties, and pharmacokinetic studies of N2-phenylguanine derivatives as inhibitors of herpes simplex virus thymidine kinases. |
AID210712 | Inhibition of TdR phosphorylation using thymidine kinase assay for herpes simplex virus type 1 | 1990 | Journal of medicinal chemistry, Jan, Volume: 33, Issue:1
| Structure-activity relationships of N2-substituted guanines as inhibitors of HSV1 and HSV2 thymidine kinases. |
AID22429 | Volume of distribution in mice plasma was determined at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle | 1995 | Journal of medicinal chemistry, Jan-06, Volume: 38, Issue:1
| Synthesis, properties, and pharmacokinetic studies of N2-phenylguanine derivatives as inhibitors of herpes simplex virus thymidine kinases. |
AID210711 | Inhibitory activity against HSV-1 thymidine kinase isolated from HeLa cells | 1992 | Journal of medicinal chemistry, Aug-07, Volume: 35, Issue:16
| Quantitative structure-activity relationships of N2-phenylguanines as inhibitors of herpes simplex virus thymidine kinases. |
AID14667 | Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle | 1995 | Journal of medicinal chemistry, Jan-06, Volume: 38, Issue:1
| Synthesis, properties, and pharmacokinetic studies of N2-phenylguanine derivatives as inhibitors of herpes simplex virus thymidine kinases. |
AID210716 | Inhibition of TdR phosphorylation using thymidine kinase assay for herpes simplex virus type 2 | 1990 | Journal of medicinal chemistry, Jan, Volume: 33, Issue:1
| Structure-activity relationships of N2-substituted guanines as inhibitors of HSV1 and HSV2 thymidine kinases. |
AID210715 | Inhibition of HSV-2 thymidine kinase, 2 uM [3H]thymidine and ATP as phosphate donor | 1995 | Journal of medicinal chemistry, Jan-06, Volume: 38, Issue:1
| Synthesis, properties, and pharmacokinetic studies of N2-phenylguanine derivatives as inhibitors of herpes simplex virus thymidine kinases. |
AID25174 | Half life in mice plasma was determined at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle | 1995 | Journal of medicinal chemistry, Jan-06, Volume: 38, Issue:1
| Synthesis, properties, and pharmacokinetic studies of N2-phenylguanine derivatives as inhibitors of herpes simplex virus thymidine kinases. |
AID326127 | Inhibition of Herpes B virus recombinant thymidine kinase-mediated [3H]TdR phosphorylation | 2007 | Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
| Sensitivity of monkey B virus (Cercopithecine herpesvirus 1) to antiviral drugs: role of thymidine kinase in antiviral activities of substrate analogs and acyclonucleosides. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |